Pulmonary vasodilatory effects of 12 and 60 parts per million inhaled nitric oxide in children with ventricular septal defect
- 15 January 1995
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (2) , 196-198
- https://doi.org/10.1016/s0002-9149(00)80080-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease.Heart, 1994
- Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose responseThe Journal of Pediatrics, 1994
- Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.Circulation, 1993
- Inhaled nitric oxide: dose response and the effects of blood in the isolated rat lungJournal of Applied Physiology, 1993
- Time‐course and dose‐response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndromeEuropean Journal of Clinical Investigation, 1993
- Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxideThe Journal of Pediatrics, 1993
- Inhaled nitric oxide in congenital heart disease.Circulation, 1993
- Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics.Circulation, 1993
- Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.Circulation, 1991
- Impairment of pulmonary endothelium‐dependent relaxation in patients with Eisenmenger's syndromeBritish Journal of Pharmacology, 1990